Evolocumab, efficacia ipolipemizzante e sicurezza costanti a ogni stadio di malattia renale cronica
Pharmastar Italy,
Pubblicata sul "Journal of American College of Cardiology", una recente analisi dello studio FOURIER, condotto con evolocumab…
Pubblicata sul "Journal of American College of Cardiology", una recente analisi dello studio FOURIER, condotto con evolocumab…
Evolocumab used along with statins is effective in reducing low-density lipoprotein cholesterol (LDL-C) and the risk for…
Evolocumab used along with statins is effective in reducing low-density lipoprotein cholesterol (LDL-C) and the risk for…
MedicalResearch.com Interview with: Dr. Charytan David Charytan, MD MSc Chief, Nephrology Division NYU Langone Medical Center…